PROVIDER PROFILE · NPI 1427292093

Jemilat BadamasM.D

PRACTICEKAISER PERMANENTE MASSee all providers at this practice →

Internal MedicineLargo, MDI

MEDICARE UTILIZATION · PART B · 2024

No data available for this provider in 2024.

PRESCRIBING · PART D · 2024

Total Rx claims

642

Beneficiaries

—

Total drug cost

$84K

Distinct drugs

Brand share

55.0%

Top prescribed drugs

Peg3350/Sod Sulf,bicarb,cl/Kcl259 claims

Pantoprazole Sodium113 claims

Peg3350/Sod Sul/Nacl/Kcl/Asb/C66 claims

Famotidine51 claims

Lubiprostone41 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

No data available for this provider in 2024.

REFERRAL NETWORK

Where Jemilat Badamas's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 0 inbound referrers · 2 outbound destinations.

Receives referrals from

Inbound — who sends patients here

No inbound pairs above the suppression threshold.

Refers patients to

Outbound — where patients go next

Physician	Patients	Visits
MEZEY, ESTEBAN	14	17
THE JOHNS HOPKINS HOSPITAL	14	23

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history